Morphine Sulfate (Page 9 of 9)

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL — 30 mg Suppository Carton

Rx Only

Morphine Sulfate Suppositories 30 mg

FOR RECTAL USE ONLY

Warning: May be habit forming.

Dispense the accompanying Medication Guide to each patient

12 Suppositories

UNIT DOSE

morphine-sulfate-suppositories-30-mg-carton
(click image for full-size original)

The following image is a placeholder representing the product identifier that is either affixed or imprinted on the drug package label during the packaging operation.

serialization-template
(click image for full-size original)
MORPHINE SULFATE
morphine sulfate suppository
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0574-7110
Route of Administration RECTAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MORPHINE SULFATE (MORPHINE) MORPHINE SULFATE 5 mg
Inactive Ingredients
Ingredient Name Strength
BUTYLATED HYDROXYTOLUENE
BUTYLATED HYDROXYANISOLE
GLYCERYL MONOSTEARATE
SILICON DIOXIDE
POLYSORBATE 80
HYDROGENATED PALM KERNEL OIL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0574-7110-12 12 PACKET in 1 BOX contains a PACKET
1 1 SUPPOSITORY in 1 PACKET This package is contained within the BOX (0574-7110-12)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 09/01/1990
MORPHINE SULFATE
morphine sulfate suppository
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0574-7112
Route of Administration RECTAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MORPHINE SULFATE (MORPHINE) MORPHINE SULFATE 10 mg
Inactive Ingredients
Ingredient Name Strength
BUTYLATED HYDROXYTOLUENE
BUTYLATED HYDROXYANISOLE
GLYCERYL MONOSTEARATE
SILICON DIOXIDE
POLYSORBATE 80
HYDROGENATED PALM KERNEL OIL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0574-7112-12 12 PACKET in 1 BOX contains a PACKET
1 1 SUPPOSITORY in 1 PACKET This package is contained within the BOX (0574-7112-12)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 09/01/1990
MORPHINE SULFATE
morphine sulfate suppository
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0574-7114
Route of Administration RECTAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MORPHINE SULFATE (MORPHINE) MORPHINE SULFATE 20 mg
Inactive Ingredients
Ingredient Name Strength
BUTYLATED HYDROXYTOLUENE
BUTYLATED HYDROXYANISOLE
GLYCERYL MONOSTEARATE
SILICON DIOXIDE
POLYSORBATE 80
HYDROGENATED PALM KERNEL OIL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0574-7114-12 12 PACKET in 1 BOX contains a PACKET
1 1 SUPPOSITORY in 1 PACKET This package is contained within the BOX (0574-7114-12)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 09/01/1990
MORPHINE SULFATE
morphine sulfate suppository
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0574-7116
Route of Administration RECTAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MORPHINE SULFATE (MORPHINE) MORPHINE SULFATE 30 mg
Inactive Ingredients
Ingredient Name Strength
BUTYLATED HYDROXYTOLUENE
BUTYLATED HYDROXYANISOLE
GLYCERYL MONOSTEARATE
SILICON DIOXIDE
POLYSORBATE 80
HYDROGENATED PALM KERNEL OIL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0574-7116-12 12 PACKET in 1 BOX contains a PACKET
1 1 SUPPOSITORY in 1 PACKET This package is contained within the BOX (0574-7116-12)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 09/01/1990
Labeler — Padagis US LLC (967694121)

Revised: 12/2021 Padagis US LLC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.